The Week Ahead: Fed...
Health Care: Drugs
Athersys Inc. (ATHX: OTC)
$1.41 -0.07 | -4.73%
06/01/12 - 03:59 PM ET
Company Cash Flow
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -13.75M | -11.38M | -15.37M | -17.99M |
| Operating Gains/Losses | 628.00K | 0.00 | -21.00K | -7.00K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 1.74M | -1.85M | -87.00K | 447.00K |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 983.00K | 562.00K | 479.00K | -496.00K |
| (Decrease) Increase In Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Working Capital | -3.66M | 165.00K | 6.58M | 0.00 |
| Other Non-Cash Items | -260.00K | 1.47M | 2.81M | 1.93M |
| Net Cash From Continuing Operations | -14.49M | -10.59M | -4.62M | -15.71M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -14.49M | -10.59M | -4.62M | -15.71M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 21.00K | 24.00K |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 21.67M | 10.75M | 15.30M | 43.92M |
| Purchases of Property, Plant & Equipment | -590.00K | -390.00K | -381.00K | -532.00K |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | -12.51M | 0.00 | -11.69M | -26.59M |
| Other Cash from Investing Activities | 0.00 | 0.00 | -14.00K | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 8.57M | 1.53M | 3.23M | 16.82M |
| Issuance of Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 12.60M | 0.00 | 0.00 | 0.00 |
| Repayment of Long-Term Debt | 0.00 | 0.00 | 0.00 | -1.80M |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Cash From Financing Activities | 12.60M | 0.00 | 0.00 | -1.80M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | 6.68M | -9.06M | -1.38M | -696.00K |
Portfolios with ATHX
- Portfolio NameUser Type
- Contributor10 Cheap Biotech Stocks Tha...
- UserAlfa
- Contributor9 Health Care Stocks With 1...
- Contributor10 Pharma Stocks With 100% ...
- Contributor10 Biotech Stocks Expected ...
- UserFuture Speculation
- User©SUPRATRADE HOT STOCKS (...
- UserBesV Portfolio 1
- Userdawnf Portfolio 1
- UserMangar's picks
Latest ATHX Headlines from TheStreet
- Aastrom Raises Cash To Fund Pivotal Trial 03.09.12 | 12:03 pm
- Athersys Reports Fourth Quarter And 2010 Annual Results 03.14.11 | 04:03 pm
- Athersys Announces Initiation Of Patient Enrollment For Phase II Clinical Trial In Inflammatory Bowel Disease 03.14.11 | 07:03 am
- Athersys To Host Fourth Quarter Financial Results Call 02.18.11 | 07:02 am
- Researchers From UTHealth And Athersys Present Preclinical Data Illustrating Potential Benefits Of MultiStem(R) For Treating Stroke 02.10.11 | 07:02 am
- Athersys To Present At 13th Annual BIO CEO & Investor Conference 02.08.11 | 02:02 pm
- 10 Pharma Stocks With 100% Buy Ratings 02.03.11 | 11:02 am
- Athersys Announces Registered Direct Offering Of $13.1 Million 01.28.11 | 09:01 am
- Researchers From Case Western Reserve And Athersys Publish Landmark Study Showing Regenerative Benefit Of MultiStem Therapy After Spinal Cord Injury 01.19.11 | 07:01 am
- Athersys Announces Completion Of Patient Enrollment For Single Dose Arm Of Phase I Study Of MultiStem(R) For Hematopoietic Stem Cell Transplant Support 01.06.11 | 07:01 am
Press Releases for ATHX
- Athersys, Inc. - Retail Investor Conferences.com Presentation Now Available Online - PR Newswire 01.24.11 | 12:01 pm
- RTI Biologics And Athersys Announce Collaboration In The Orthopedic Market - Business Wire 09.13.10 | 07:09 am
Partner Headlines for ATHX
- Follow the Analyst Leader: New Stock Coverage to Watch - Wall St. Cheat Sheet 05.31.12 | 04:05 am
- Microcap Movers for Friday December 2 , 2011 - Benzinga 12.02.11 | 05:12 pm
- Zacks #5 Rank Additions for Thursday - Tale of the Tape - Zacks 09.29.11 | 09:09 am
- Zacks #5 Rank Additions for Friday - Tale of the Tape - Zacks 09.23.11 | 09:09 am
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 08.31.11 | 09:08 am
- Zacks #5 Rank Additions for Friday - Tale of the Tape - Zacks 08.26.11 | 09:08 am
- Zacks #5 Rank Additions for Friday - Tale of the Tape - Zacks 08.12.11 | 09:08 am
- Athersys Q2 Loss Is Slight Improvement Over Previous Year - Seeking Alpha 08.11.11 | 09:08 am
- Zacks #5 Rank Additions for Tuesday - Tale of the Tape - Zacks 05.10.11 | 09:05 am
- 4 Biotech Companies That Could Be Buyout Targets - Seeking Alpha 04.05.11 | 08:04 am
